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Biopsychosocial predictors of fatigue in quiescent and
mild ulcerative colitis: an explorative study
BiopsychosozialePrädiktorenvonMüdigkeit(Fatigue)beiPatientenmit
Colitis ulcerosa in Remission und leichter Krankheitsaktivität: eine
explorative Studie
Abstract
In 37 patients with ulcerative colitis (UC) and ileal pouch-anal anasto-
mosis (IPAA) and 40 patients without IPAA fatigue was measured using
Winfried Häuser
1
Andreas Stallmach
2
the Short Form Gießen Subjective Complaints List GBB 24. Age, sex,
Rueya-
Daniela Kocalevent
3
disease activity (measured by the Colitis Activity Index CAI or the Pouch
Disease Activity Index PDAI) and depressiveness (measured by the
HospitalAnxietyandDepressionScaleortheCenterforEpidemiological Matthias Rose
3
Studies Depression Scale), active medical comorbidities and therapy
Herbert Fliege
3
by corticosteroids were tested for their predictive capacity regarding
fatigue. One third of the patients indicated fatigue scores above the
95th percentile of the score of the general German population. The 1 Department of Internal
MedicineI(Gastroenterology, amount of fatigue in patients without IPAA was best predicted by the
degree of depressiveness (corrected R
2=0.30, β=0.57, p<0.001). The Hepatology, Endocrinology,
Infectious Diseases, amount of fatigue in patients with IPAA was best predicted by the PDAI-
score (corrected R
2=0.20, β=1.35, p=0.03). Psychosomatics), Klinikum
Saarbrücken, Saarbrücken,
Germany Keywords: fatigue, ulcerative colitis, ileal pouch-anal anastomosis,
depressiveness, Inflammatory Bowel Disease Questionnaire 2 Department of
Gastroenterology,Hepatology Zusammenfassung
Bei 37 Patienten mit Colitis ulcerosa (CU) und ileoanalem Pouch (IPAA)
sowie 40 Patienten ohne IPAA wurde Fatigue mittels des Gießener Be-
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medizinischer Komorbiditäten sowie aktueller Kortikosteroidtherapie
wurden mittels einer multiplen Regressionsanalyse untersucht. Ein
Drittel der Patienten gab Fatigue-Werte jenseits der 95%-Perzentile (im
VergleichzueinerrepräsentativenBevölkerungsstichprobe)an.Fatigue
bei Patienten ohne IPAA wurde durch das Ausmaß der Depressivität
(korrigiertes R
2=0.30, β=0.57, p<0.001), bei Patienten mit IPAA durch
den PDAI-Score (korrigiertes R
2=0.20, β=1.35, p=0.03) vorhergesagt.
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Introduction
Fatigue-definedasthesubjectiveexperienceofreduced
physical and/or mental energy/vitality - is a common
symptominthegeneralpopulationandinseveralsomatic
diseases such as chronic hepatitis C, multiple sclerosis,
or in long-term survivors of cancer [1], [2], [3], [4], [5]. It
is seen as well in patients affected by mental disorders
such as depression [6]. "Fatigue" is a multidimensional
construct with a cognitive, physical and mental/psycho-
logicaldimension[2]whichisnearlynormallydistributed
in the general population [7]. Fatigue related to somatic
1/8 GMS Psycho-Social-Medicine 2005, Vol. 2, ISSN 1860-5214
Research Article OPEN ACCESSdiseases (chronic hepatitis C for example) had been re-
ported to adversely affect functional capacity and work
performance. Studies on its predictors in the general
population and different diseases showed that fatigue is
determined as well as by sociodemographicfactors such
as age und sex [7], psychologicalfactors such as depres-
siveness [2], [3] and psychopharmacological treatment
[6]. Although fatigue and depression are different con-
structs, there is a considerable overlap between them.
To put it at its simpliest, a part of those who complain of
fatiguewillbedepressedbutnearlyeveryonewithamajor
depression will also experience fatigue [2].
Fatigue has only recently gained the attention of gastro-
enterologists in quiescent inflammatory bowel disease
(IBD). In a Dutch study more than 40% of IBD-patients in
remission suffered from fatigue. 40% of the patients in
remission suffered from a higher level of fatigue com-
pared to age and sex matched healthy controls. No cor-
relations could be found between fatigue, basal cortisol
levels or other laboratory parameters. A correlation
between fatigue and an impaired health related quality
of life (HRQOL) was noted. The impact of fatigue on the
social domains of HRQOL compared to other IBD-symp-
toms such as abdominal pain and diarrhea was not in-
vestigated. Patients with an ileostomy/colostomy or an
ileal pouch-anal anastomosis (IPAA) were not included in
the study. The authors concluded that further research
into the pathogenesis of fatigue in IBD is warranted [8].
The purpose of the present study was to extend previous
findingsofpossibledeterminantsoffatigueinIBD-outpa-
tientsinremissionorwithslightdiseaseactivitybecause
somatic causes of fatigue such as severe anemia can be
excluded in these patients. Because IBD-patients in re-
mission and with slight disease activity are able to work,
the relationship of fatigue with social functioning is of
particular interest. The aims of our study thus were
- to compare the subjective burden of fatigue in UC-pa-
tients with the general German populationby a validated
self-report questionnaire,
- to compare the relative predictive value of fatigue on
physical and social domains of HRQOL to that of bowel
symptoms,
- to assess possible disease-related (disease activity,
medication), psychological (depressiveness) and socio-
demographic (age, sex) factors predicting fatigue in pa-
tients with quiescent and mild ulcerative colitis (UC) with
and without IPAA.
Material and methods
Patients
The study was a secondary analysis of data on HRQOL
gathered in studies validating the German version of the
Inflammatory Bowel Disease Questionnaire (IBDQ) in pa-
tients with ulcerative colitis and ileal pouch-anal anasto-
mosis (IPAA) and restorative proctocolectomy [9] and the
GermanversionoftheShort-IBDQ(SIBDQ-D)inpatients
with UC and Crohn's disease (CD) [10]. Because in the
study of Minderhoud and coworkers CD- and UC-patients
differedintheirlevelsoffatigue(8)weanalysedonlydata
of the UC-patients of the SIBDQ-D sample.
UC-patients with IPAA: Participants for this study were
recruitedintwoways.MembersoftheworkinggroupIPAA
oftheGermanMorbusCrohn/ColitisulcerosaFoundation
(DCCV), and patients with IPAA and UC who had been
operated in the department of general surgery or had
been treated in the medical IBD-outpatient department
of the Universitätskliniken des Saarlandes (Germany)
from January 1993 to December 2002 were contacted
by a letter inviting them to take part in a study on HRQOL
andpouchitis.TheaddresslistsoftheDCCVincludednot
onlypatientswithIPAAbutalsoIBD-patientswithoutIPAA
and relatives. Due to German laws on data protection a
selective addressing of IPAA-patients was not possible.
The patients of the DCCV had been operated on other
surgicalcentersthantheuniversityoftheSaarland.Inclu-
sion criteria were age >18 years, UC in history confirmed
by biopsy and an ability to read German. Patients who
showed interest to take part in the study were contacted
by a second letter scheduling the examination which in-
cluded physical examination, endoscopy of the pouch
and a set of questionnaires The questionnaires were to
be answered 8 days before the examination.
UC-patientswithoutIPAA: Consecutiveoutpatientsofthe
gastroenterological department of the Virchow-Klinikum
Charité in the Humboldt-University of Berlin were asked
during regular outpatients visits to take part in the study.
Inclusion criteria were age ≥18 years, IBD in history con-
firmed by biopsy and an ability to read German. The cur-
rent medication and symptoms and the the medical his-
tory were assessed in an interview.
Disease activity scores and
questionnaires
Disease activity in IPAA-patients was measured by the
Pouchitis Activity Index (PDAI) [11]. To calculate the clin-
icalsubscoreofthePDAI,patientsansweredthe medical
questionnaire of the German competence network
"Chronic inflammatory bowel disease". It includes ques-
tions regarding the history of the IBD, current symptoms,
currentextraintestinalmanifestations,presentmedication
and also questions regarding IPAA [9]. In IPAA-patients
endoscopy scores were calculated by endoscopists not
aware of the patients' clinical history. No patient had an
anastomotic stricture, pouch outlet obstruction, perianal
abscess or external fistula. A single pathologist blinded
totheclinicalpresentationandclinicalfindingsassessed
pouch biopsies for the grade of inflammation based on
the criteria of Sandborn. Pouchitis was diagnosed if the
Pouchitis Activity Index (PDAI) was ≥7 [11]. Disease
activity was measured in UC by the Colitis Activity Index
(CAI) [12]. Quiescent disease was defined by a CAI
between 0-3 and slight disease activity by a CAI between
4-6. The clinical and laboratory data necessary to calcu-
late the CAI were gathered from medical records.
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jective Complaints List GSCL was used to measure fa-
tigue. With 24 items on a 5-point Likert scale ranging
from 0 (no suffering from this symptom) to 4 (severe
suffering from this symptom) bodily symptoms can be
assessed in 4 subscales (fatigue, dyspeptic symptoms,
musculoskeletalsymptoms,cardiorespiratorysymptoms
and a total score). Within the subscales scores range
from 0-24 and in the total score from 0-144 with 0 indi-
cating no suffering from bodily symptoms and 24, 144
respectively severe suffering from bodily symptoms. The
GSCL has been developed and validated in German and
proved to be reliable and valid [13]. We compared the
fatigue-scores of the GSCL in the study sample with a
representative sample (as to the distribution of age, sex
and education) of the German population (N=1943
people) which was recruited 1994 by an independent
service of surveys, methods and analyses [13].To allow
comparisonswiththestudyofMinderhoudandcoworkers
[8] we defined (exceptional) fatigue by a GSCL-fatigue
score >10 (95 percentile in the representative sample of
the German population).
HRQOL was measured in IPAA-patients by the German
version of the IBDQ [9], [14] and in UC-patients by the
German version of the SIBDQ [10], [15]. The (S)IBDQ is
an IBD-specific questionnaire containing 32 (10) items
with a graded response rate ranging from 1 (worst) to 7
(best) and a possible total score of 32-224 (10-70). The
32(10)itemscanbearrangedinfourdimensionalscores:
Bowel symptoms 10 (3) items, systemic symptoms 5 (2)
items (including fatigue), emotional well-being 12 (3)
items and social functioning 5 (2) items [7], [16]. The
Canadian (S)IBDQ has been translated to German by a
forward-backwardprocedureandhasundergonerigorous
psychometrictestingprovingagood(sufficient)reliability
and validity [9], [10]. To avoid interferences of symptoms
with functioning the subscale "Social" of the (S)IBDQ not
including somatic symptoms was used as dependent
variable to assess the impact of fatigue compared to in-
testinal symptoms on the social domain of HRQOL. Add-
itionally in IPAA-patients HRQOL was measured by the
German version of the Medical Outcome Study Short-
Form 36 (SF-36 Items). The SF-36 is a reliable and valid
instrument measuring all domains of the health status.
It covers 4 domains in the area of physical health (phys-
ical functioning, role limitation - physical, bodily pain and
general health) and 4 domains in the area of mental
health (role limitation - emotional, vitality, mental health
and social functioning). Two comprehensive indexes of
HRQOL can also be computed (physical component
summary and mental component summary). The re-
sponses to the questions in each domain are added to
provide eight scores between 0 and 100 with higher
scores reflecting better HRQOL. The mean of the two
comprehensive scores is 50 with a standard error of the
mean (SEM) of 10 [16]. The SF-36 has been translated
by a forward-backward procedure into German and the
translated version proved to be reliable and valid. Data
from a representative sample of the German population
as well as from medically ill and mentally disordered
populations are available [17]. To avoid interferences of
symptoms with functioning the subscales "Physical and
social functioning" of the SF-36 not including somatic
symptoms were used as dependent variable to assess
the impact of fatigue compared to intestinal symptoms
on the physical and social functioning.
Psychological distress was measured by the Allgemeine
Depressionskala (ADS) in UC-patients without IPAA and
bytheGermanversionofthe HospitalAnxietyandDepres-
sion Scale (HADS-D) in UC-patients with IPAA. The ADS is
a German version of the Center for Epidemiological
Studies Depression Scale (CES-D) [18], [19]. With 15
items(ShortFormADS-K)ona4-pointLikertscaleranging
from0(rarelyofthetime)to3(mostofthetime)emotion-
al, somatic and cognitive symptoms of depressive mood
can be assessed. Respondents who score >17 on the
total score are regarded as having a symptom severity of
depressionindicativeofaprobablepsychologicaldisorder.
The ADS has been translated by forward-backward pro-
cedure into German and proved to be reliable and valid.
Normative data of the German version ADS-(K) from a
general German population as well as from large inter-
national medically ill populations are available [19]. The
Hospital Anxiety and Depression Scale HADS-D was
specifically designed for the assessment of anxiety and
depression in patients with physical illness. With 7 items
eachona4-pointLikertscalerangingfrom0(notpresent)
to3(alwayspresent)asubscalescoreforthe2subscales
anxiety and depression can be calculated. Respondents
whoscore≥11oneithersubscaleareregardedashaving
a symptom severity of depression or anxiety indicative of
aprobablepsychologicaldisorder(i.e.clinicaldepression
oranxietydisorder)[20].TheHADS-Dhasbeentranslated
by forward-backward procedure into German and proved
to be reliable and valid [21]. Normative data of the valid-
ated German version HADS-D from a general German
population as well as from large international medically
ill populations are available [21], [22].
Statistical analysis
Up to one missing item of each scale of the question-
naires was replaced by the "individual" median of the
items subscale (with the exception of the SIBDQ-D). If
morethanoneitemwasmissingtherespectivequestion-
naire was excluded form further analysis. All data were
analysedusingWinstatforExcel(Version2001.1,R.Fitch
Software,Staufen, Germany). Dataderived from descrip-
tive statistical analysis are presented in the form of per-
centages for categoric variables and for continuous data
asmean±onestandarddeviation(SD)andrangeand/or
as median and interquartile ranges (25-75 percentiles).
Most variables are not normally distributed. To allow
comparisons with the results of other studies both mean
and median are presented in the tables. Comparisons of
variables between groups were performed by parametric
(student's t-test) for comparisons with the data of the
general population (because only mean and SD were
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test,Chi-Squaretest)forcomparisonsbetweenthediffer-
ent groups of patients with UC. The level of significance
was set at α<0.05 (two-sided) in case of single compari-
sons.EffectsizeswerecalculatedbythemethodofCohen
[23].
In patients with IPAA stepwise multiple regression ana-
lyses with p in and out =0.05 were performed to assess
the impact of fatigue (IBDQ Item 2) compared to other
intestinal symptoms of IBD (Number of stools -IBDQ Item
1; Liquidity of stools - IBDQ Item 5; Abdominal cramps -
IBDQItem9;Abdominalpain-IBDQItem13;Passinggas
- IBDQ Item 17; Bloating - IBDQ Item 20; Rectal bleeding
- IBDQ Item 22; Going to bathroom despite empty bowels
- IBDQ Item 24; Soiling underwear - IBDQ Item 26) in the
IBDQ subscales "Social" and the SF-36 subscales "Phys-
ical Functioning", "Physical Role Limitation" and "Social
Functioning".InpatientswithoutIPAAthepredictivevalue
of fatigue (SIBDQ Item 1) compared to other intestinal
symptomsofIBD(Abdominalpain-SIBDQItem4;Passing
gas - SIBDQ Item 6; Going to bathroom despite empty
bowels - SIBDQ Item 9) was tested with the SIBDQ sub-
scale "Social" (SIBDQ Items 2 and 3) as dependent vari-
ables.
Stepwise multiple regression analyses with p in and out
=0.05 were performed to identify variables predicting
high scores on the subscale "Fatigue" of the GSCL. The
following seven independent variables were entered into
regression analysis for IPAA-patients:
-Medicalvariablesofthedisease:PDAI(becauseitseems
to be rather arbitrary to distinguish silent from active
pouchitis by a cut-off at seven points in the PDAI and
because the intercorrelations of the clinical, endoscopic
and histological score of the PDAI are nearly zero [24],
we entered the PDAI as ordinal data); psychopharmaco-
logical treatment (dichotomous); number of medical co-
morbidities (ordinal data); current extraintestinal mani-
festations (dichotomous);
- Depressiveness: Total Score of the subscale "Depres-
sion" of the HADS- D (ordinal data);
- Sociodemographicvariables:Age(ordinaldata)andsex
(dichotomous).
Thefollowingsixindependentvariableswereenteredinto
regression analysis for UC-patients without IPAA:
- Medical variables of the bowel disease: CAI (ordinal
data);treatmentbycorticosteroids(dichotomous);number
of medical comorbidities (ordinal data)
-Depressiveness:TotalScoreoftheADS-K(ordinaldata);
-Sociodemographicvariables:Age(ordinaldata)andsex.
Ethics
All patients gave their voluntary informed consent after
fullwrittenexplanationoftheaimsofthestudy,including
considerations regarding ethics and data protection and
the anonymous deposition of the questionnaires apart
from the medical charts. The study was approved by the
ethics committee of the board of physicians of the Saar-
land (Rec. 08/03) and the medical faculty of the Hum-
boldt-University of Berlin (Rec. 107/99).
Results
To estimate the enrollment rate of IPAA-patients we sup-
posed that 70 of the 280 members of the working group
IPAA of the DCCV were IPAA-patients, the others being
eithermemberspriortosurgicalinterventionorrelatives.
45 of these 70 were interested in getting further infor-
mationregardingthestudy.From18ofthese70patients
(25.7%)acompletedataset(endoscopy,questionnaires)
wasavailable.34of61(55.7%)patientsoftheuniversity
of the Saarland were interested in getting further infor-
mationregardingthestudy.From19ofthese34patients
(55.8%)acompletedataset(endoscopy,questionnaires)
was available. Altogether the estimated enrollment rate
was 37/131 (28.9%). None of the included patients had
to be excluded due to more than one missing item in any
subscale of the questionnaires.
Out of the 142 consecutive patients with IBD (UC and
CD)approached125(86.8%)agreedtoparticipateinthe
study and completed questionnaires. 90/142 data sets
were available for analysis (60.6%). 44 (48.9%) of the
patients were diagnosed with ulcerative colitis (UC) and
46(51.1%)withCrohn'sdisease(CD).Dataofthepatients
withCDarenotpresentedinthispaper. FourUC-patients
had to be excluded due to more than one missing item
inatleastonesubscaleofthequestionnaires.Sociodemo-
graphic and medical data of the patients are presented
in Table 1.
Thefatigue-meanvalues±oneSDofthegeneralGerman
population and the study groups of UC-patients are
presented in Figure 1. The median (25%-75% percentile;
range)ofthescalefatigueoftheGSCLwas6.5(2-12.25,
0-20) in patients with IPAA and 7 (3-13;0-22) in patients
without IPAA. Only the mean ± one SD of the general
Germanpopulation(4.01±4.25)isavailable.Bothgroups
of UC-patients complained about a higher degree of fa-
tigue than the general German population (t=-7.32, a
posteriori effect size =1.25 [with IPAA]; t=-5.07 , a pos-
teriori effect size =0.92 [without IPAA]; both p's <0.001).
28.9%ofthepatientswithIPAAand33.3%ofthepatients
without IPAA were above the 95% percentile of the score
from the general German population. There were no sig-
nificant differences in the level of fatigue or in the per-
centage of patients above the 95% percentile of the
General German population between patients with and
without IPAA (Chi
2=0.13; p=0.71) The impact of fatigue
in the physical and social functioning measured by the
IBDQ-D and the SF-36 in patients with IPAA is shown in
Table 2.
Independently from gastrointestinal symptoms, fatigue
had a small, but significant additional predictive value
for the physical functioning and the social functioning as
measured by the SF-36 and the IBDQ-D. In patients
without IPAA social functioning in the SIBDQ-D (items No
2 and 3) was predicted by abdominal pain (item No 4)
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Figure 1: Fatigue measured by the Giessen Subjective Complaints List GSCL in the general German population and in patients
with ulcerative colitis with and without ileal pouch-anal anastomosis (IPAA)
5/8 GMS Psycho-Social-Medicine 2005, Vol. 2, ISSN 1860-5214
Häuser et al.: Biopsychosocial predictors of fatigue in quiescent ...Table2:Multiplestepwiseregressionanalysingthepredictivevalueoffatigueonthedomainsofphysicalandsocialfunctioning
of health related quality of life in patients with ulcerative colitis and ileal pouch-anal anastomosis, comparing it to other
gastrointestinalsymptoms(measuredbyisolateditemsoftheGermanversionoftheInflammatoryBowelDiseaseQuestionnaire
IBDQ-D)
Table 3: Multiple stepwise regression identifying predictors of fatigue (measured by the Giessen Subjective Complaints list
GSCL) in patients with ulcerative colitis with and without and ileal pouch-anal anastomosis
(corrected R
2=0.40, β=0.68, p=0.0007), "having to go to
bathroom despite empty bowels" (item No 9) (corrected
R
2=0.55, β=0.62, p=0.002) and fatigue (item No 1)
(corrected R
2=0.61, β=0.45, p=0.01).
Using multiple stepwise regression analyses the amount
of fatigue in IPAA-patients measured by the GSCL was
predicted by the PDAI (corrected R
2=0.20, β=1.35,
p=0.03) and in patients without IPAA by the ADS- total
score (corrected R
2=0.30, β=0.57, p=0.0005), whereas
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(see Table 3).
Discussion
In this exploratory study the impact of fatigue on HRQOL
in patients with ulcerative colitis was assessed and
compared with the effect of bowel symptoms on HRQOL.
Potentialbiopsychosocialpredictorsoffatigueinpatients
with UC were tested for. The main results of our study
can be summarized as follows:
-ApproximatelyonethirdoftheUC-patientssufferedfrom
aleveloffatiguehigherthantheoneinthegeneralpopu-
lation.
- Fatigue was experienced to be more disabling by IPAA-
patients than most of the bowel symptoms.
-ThelevelofdiseaseactivitycouldpredictfatigueinIPAA-
patients, depressiveness predicted fatigue-scores in pa-
tients without IPAA.
The 30% of fatigue-scores in individual patients surpas-
sing the 95-percentile of the German norm in our study
are lower than the 40% seen in the study of Minderhoud
and coworkers [8]. The use of different instruments for
theassessmentoffatigueanddifferentcriteriaforselect-
ing the study-groups might account for that. In the Ger-
man norm-sample nobody was excluded because of a
given disease, whereas in the Dutch study only explicitly
healthy people were taken as controls. In a recent study
Björnsson and coworkers demonstrated a higher level of
fatigue in Swedish IBD-patients compared to age- and
sex-matched controls from the general population too
without using percentiles [25].
In contrast to findings in the general German population
[8], [13], age and sex had no influence on fatigue in our
study. An age-related increase of fatigue in the general
population starts with the age of 40 years and increases
every decade [13]. Because most of our patients were
between 30 and 50 years of age we might have missed
todemonstrateaneffectofageonfatigueinUC-patients.
Wedidnotfindanydifferencesbetweenmaleandfemale
patients neither in the level of fatigue nor in the level of
depressiveness (data not presented). We were able to
confirmourhypothesisonthepredictivevalueofdepres-
siveness on fatigue only in UC-patients without IPAA.
Perhaps this finding is due to the fact that the rate of
IPAA-patients taking psychopharmacological agents
(35.3%) was higher than the one in the group without
IPAA (6.5%), with a possible effect of a reduction of clin-
ical depressiveness in our IPAA-patients. Yet we did not
differentiate in the questionnaire or in the clinical inter-
view between different types of psychopharmacological
agents.TheSwedishstudyalsofounddepressivenessas
a predictor of fatigue in patients with primary sclerosing
cholangitis with and without IBD [25]. Only in IPAA-pa-
tients disease activity could significantly predict fatigue.
This could be due to the different weight of subjectively
experienced symptoms in the CAI and PDAI. One third of
thescoreofthePDAIisdefinedby(four)rathersubjective
symptoms[11]whereastheCAIiscomposedbyonesuch
symptom and six objective findings [12]. If in the IPAA-
patientsonly the endoscopicor histologicalscoresof the
PDAI would be entered into multiple regression analyses
instead of the total score, we would have failed to
demonstrate any predictive value of the PDAI for the
subscales of the IBDQ-D. Therefore our data confirm the
findings of Minderhoud and coworkers [8] that fatigue in
UC-patients is (mainly) independent from objective dis-
ease measures in quiescent disease. Our findings lead
to the assumption that this is true also for patients with
mild disease activity.
Some limitations of our study must be considered: The
total enrollment rate (37% for the whole sample) was
rather low. Especially in the IPAA-sample a selection bias
for motivated and active patients is possible. If this as-
sumption were true, selection biases due to restriction
ofpatientsoftertiarycenterswouldbecounterbalanced.
Nevertheless our data might not be representative for all
patientswithUC.Weretrospectivelycompareddatafrom
two different studies that used partially different clinical
and psychometric instruments. Any prospective study
could provide results more reliably. Yet data exchange of
two German groups working on HRQOL in IBD seemed to
be appropriate for the explorative aims of the study. Al-
though the investigators collecting the questionnaires
were different (gastroenterologists in IPAA-patients, psy-
chologistsintheothergroup)wedonotseeasubstantial
risk of a measurement bias because in both settings
standardized instructions for the patients to fill out the
questionnaires were used. It would be more appropriate
to compare the patients with Crohn's disease and ulcer-
ative colitis and both IBD-diseases with subgroups of the
general population which are matched for age, sex and
jobsituation.Thereforetherobustnessofourexploratory
findingsmustbetestedbybiggersamplesizes.Especially
the role of disease activity taking into account other
possible determinants of fatigue such as the course of
the IBD (stable remission, rare or frequent flare ups and
their former severity, chronic active disease), of somatic
and psychiatric comorbidities and of pharmacological
therapy (e.g. corticosteroids, antidepressants) deserves
further research.
Insum,wecouldnotonlydemonstrateahighprevalence
offatigueinpatientswithquiescentandslightUC-disease
activity but also a high relevance of fatigue for HRQOL.
Fatigueresearchingastroenterologyshouldbecontinued.
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